<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="92444">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01950754</url>
  </required_header>
  <id_info>
    <org_study_id>MANCKOUNDIA PHRC IR 2007</org_study_id>
    <nct_id>NCT01950754</nct_id>
  </id_info>
  <brief_title>Study of the Effect of a Cognitive Task on Static Balance in Depressive Elderly Subjects According to the Double Task Principle</brief_title>
  <acronym>DOUBLE TACHE</acronym>
  <official_title>Study of the Effect of a Cognitive Task on Static Balance in Depressive Elderly Subjects According to the Double Task Principle</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study could contribute to understanding the aggravation of balance disorders and the
      increased risk of falling in depressive people. It could, among other things, shed light on
      the impact of treatments with antidepressants on balance in treated depressive patients.
      Finally, it could contribute to improving the sensory-motor management of patients with a
      depressive syndrome.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>the difference in distance traveled by moving the center of pressure between the simple task and the dual task</measure>
    <time_frame>up to 2 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>depressive patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>nondepressed controls</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>standing with both feet</intervention_name>
    <arm_group_label>depressive patients</arm_group_label>
    <arm_group_label>nondepressed controls</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>descent of the platform</intervention_name>
    <arm_group_label>depressive patients</arm_group_label>
    <arm_group_label>nondepressed controls</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>standing on the platform, feet together and always with simultaneous performance of a task of mental count</intervention_name>
    <arm_group_label>depressive patients</arm_group_label>
    <arm_group_label>nondepressed controls</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        In the 2 groups:

          -  General and cognitive status allowing the patient, according to the evaluation of the
             investigators, to take part in the study.

          -  Patients who provide written informed consent

          -  Patients covered by the national health insurance agency

        In the &quot;depression &quot; group:

          -  Age ≥ 75 years,

          -  Subjects with a depressive syndrome, according to Geriatric Depression  Scale
             criteria.

          -  Patients without treatment with antidepressants

        In the &quot;control&quot; group:

          -  Age ≥ 75 years,

          -  Absence of a depressive syndrome

        Exclusion Criteria:

        In the 2 groups:

          -  Presence of a disabling orthopedic disease,

          -  Presence of any chronic neurological disease (cerebrovascular accident, Parkinson's
             syndrome …),

          -  Presence of a psychiatric disease apart from depression in the &quot; depression &quot; group

          -  Presence of a vestibular disease with clinical manifestations,

          -  Presence of a non-corrected visual disorder,

          -  Existence of a progressive organ disease,

          -  Psychotropic treatment able to impair vigilance and posture,

          -  Notion of one or several falls in the preceding 6 months,

          -  Oppositional personality or low motivation,

          -  Emotional or intellectual disorder.

          -  Patients under guardianship

          -  Patients who have taken part in a therapeutic trial in the previous 30 days
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>75 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Patrick MANCKOUNDIA</last_name>
    <phone>03.80.29.39.70</phone>
    <email>patrick.manckoundia@chu-dijon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick MANCKOUNDIA</last_name>
      <phone>03.80.29.39.70</phone>
      <email>patrick.manckoundia@chu-dijon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 24, 2013</lastchanged_date>
  <firstreceived_date>September 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
